Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share (KZR).
- Disclosed ownership: 9%.
- Date of event: 30 Mar 2026.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 9% ownership in Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share (KZR) on 30 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 9% | 664,314 | 0 | 664,314 | /s/ Kevin Tang | Manager | 0001232621 |
| KEVIN TANG | 9% | 664,314 | 0 | 664,314 | /s/ Kevin Tang | Self | 0001178579 |
| TANG CAPITAL PARTNERS, LP | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0001191935 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 3.7% | 272,272 | 0 | 272,272 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0002064011 |
| TANG CAPITAL PARTNERS III, INC | 5.3% | 392,042 | 0 | 392,042 | /s/ Kevin Tang | Chief Executive Officer | 0002036763 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | 0002036770 |
| CONCENTRA BIOSCIENCES, LLC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | 0001970065 |